Skip to main content

Table 1 Patient and tumour characteristics*

From: Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events

Factor

AR negative n = 32 (%)

AR positiven = 41 (%)

Age (years)

  

≤35

1 (3.0)

1 (2.4)

≥35

31 (97.0)

40 (97.6)

Estrogen receptor

  

Negative

23 (72.0)

9 (22.5)

Positive

9 (28.0)

31 (77.5)

Progesterone receptor

  

Negative

27 (87.0)

16 (39.0)

Positive

4 (13.0)

25 (61.0)

HER2

  

Negative

18 (85.7)

25 (75.8)

Positive

3 (14.3)

8 (24.2)

Triple negativea

  

No

6 (28.6)

30 (90.9)

Yes

15 (71.4)

3 (9.1)

  1. *All patients were diagnosed with Stage III disease, as defined in the Materials and Methods section of the manuscript
  2. aTriple negative breast cancer represents tumours displaying negative expression for estrogen receptor, progesterone receptor and HER2 by IHC. AR, androgen receptor; HER2, human epidermal growth factor receptor type 2.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us